Dr. Abbey and Dr. Callanan Inducted into The Retina Society
Texas Retina’s Ashkan M. Abbey, MD, and retired Texas Retina physician David Callanan, MD, were officially inducted into The Retina Society at the organization’s 57th Annual Scientific Meeting held September 11-15, in
read moreTexas Retina Honors Founder Dr. Vaiser with Donation to Retina Foundation
On behalf of the entire Texas Retina team, Gary Edd Fish, MD, recently presented a $2,000 donation to the Retina Foundation to honor the 90th birthday of one of Texas Retina’s founders,
read moreDr. Anand Presented Interim Study Results of New Gene Therapy for X-linked Retinitis Pigmentosa at ASRS 2024 Annual Meeting
Texas Retina’s Rajiv Anand, MD, presented “Subretinal AGTC-501 Gene Therapy for XLRP: 12-Month Interim Safety & Efficacy Results of the Randomized Controlled Multicenter Phase II Skyline Trial” at the 2024 Annual Meeting
read moreMay is Ocular Melanoma Awareness Month
Ocular (uveal) melanoma is a rare but dangerous disease, and only a small number of doctors in the United States treat it. At Texas Retina, we have been caring for ocular melanoma
read moreTexas Retina Associates Collaborates on Gene Therapy Research for Rare, Inherited Retina Condition
Texas Retina Associates and the Retina Foundation of the Southwest (RFSW) have been working in collaboration on new gene therapy treatments for inherited blinding diseases for which there are no cures. Most
read moreSeven Texas Retina Associates Physicians Earn New Professional Designation
The American Society of Retina Specialists has awarded its Fellow of the ASRS (FASRS) designation to the following Texas Retina Associates physicians: David Callanan, MD Rajiv Anand, MD Michel J. Shami, MD
read moreRajiv Anand, MD, Participates in Medical Mission Trip to Ulaanbaatar, Mongolia
Texas Retina Associates’ Rajiv Anand, MD, recently returned from a one-week medical mission trip to the National Medical Institute of Mongolia in Ulaanbaatar, where he operated on and assisted with 19 retina
read moreTexas Retina Associates Held 18th Annual Vitreoretinal Disease Update for Optometrists
On May 5, 2019, 180 optometrists attended Texas Retina Associates’ Vitreoretinal Disease Update 2019, an annual continuing education event held this year at the Fogelson Forum at Texas Health Presbyterian Hospital Dallas.
read moreNew AAO Video Highlights Dr. Anand Discussing Recent Clinical Trial on Ranibizumab for Patients Who Develop Radiation Retinopathy After Treatment for Uveal Melanoma
An interview with Texas Retina Associates’ Rajiv Anand, MD, is featured by the American Academy of Ophthalmology (AAO) in their latest video from the recent 2018 American Society of Retina Specialists (ASRS) annual
read more